ClinVar Miner

Submissions for variant NM_153676.4(USH1C):c.238C>G (p.Arg80Gly)

dbSNP: rs774005703
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000613861 SCV000713269 uncertain significance not specified 2017-06-18 criteria provided, single submitter clinical testing The p.Arg80Gly variant in USH1C has not been previously reported in individuals with hearing loss, but has been identified in 5/33447 Latino chromosomes and 2/5 466 chromosomes of unspecified ethnicity by the Genome Aggregation Database (gno mAD, http://gnomad.broadinstitute.org; dbSNP rs774005703). Although this variant has been seen in the general population, its frequency is not high enough to ru le out a pathogenic role. Computational prediction tools and conservation analys is do not provide strong support for or against an impact to the protein. In sum mary, the clinical significance of the p.Arg80Gly variant is uncertain.
Labcorp Genetics (formerly Invitae), Labcorp RCV001346255 SCV001540439 uncertain significance not provided 2022-07-27 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 80 of the USH1C protein (p.Arg80Gly). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with USH1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 505835). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV004024896 SCV004975764 uncertain significance Inborn genetic diseases 2024-01-16 criteria provided, single submitter clinical testing The c.238C>G (p.R80G) alteration is located in exon 3 (coding exon 3) of the USH1C gene. This alteration results from a C to G substitution at nucleotide position 238, causing the arginine (R) at amino acid position 80 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Natera, Inc. RCV001829714 SCV002087698 uncertain significance Usher syndrome type 1C 2019-11-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.